Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
15.90
-0.85 (-5.07%)
Nov 2, 2026, 4:00 PM EST - Market closed
Beta Bionics Market Cap
Beta Bionics has a market cap or net worth of $864.44 million as of November 2, 2026. It is the 10,780th most valuable company in the world and the 2,328th biggest in the United States. Its market cap has decreased by 27.86% in one year.
Market Cap
864.44M
Enterprise Value
630.33M
1-Year Change
-27.86%
Global Rank
Country Rank
#2,328 United States
Category
ChartMarket Cap Chart
Since the IPO on January 30, 2025, Beta Bionics's market cap has increased from $695.12M to $864.44M, an increase of 24.36%. That is a compound annual growth rate of 13.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 864.44M | -35.56% |
| Dec 31, 2025 | 1.34B | 92.98% |
| Jan 30, 2025 | 695.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 1.02B |
| Integra LifeSciences Holdings | 991.96M |
| IRADIMED CORPORATION | 980.60M |
| SI-BONE | 951.50M |
| QuidelOrtho | 908.62M |
| Pacific Biosciences of California | 809.71M |
| OrthoPediatrics | 806.03M |
| Cytek Biosciences | 796.80M |